Gramicidin A (GA) decreases HIF protein expression in RCC cells.

Slides:



Advertisements
Similar presentations
HMGA2 is a SUMOylation target.
Advertisements

Expression of immune checkpoint molecules on leukocytes and tumor cells at baseline and in response to selinexor. Expression of immune checkpoint molecules.
Treatment with BLU9931 leads to tumor regression in the FGF19-overexpressing PDX-derived xenograft LIXC012. Treatment with BLU9931 leads to tumor regression.
Fig. 5. Stimulation of EPO expression and secretion under hypoxic culture conditions. Stimulation of EPO expression and secretion under hypoxic culture.
HIF-1α is critically involved in hypoxia-induced CD137 upregulation.
NM-3 induces p21 levels and down-regulation of Cdk2 activity.
Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Human.
Appearance of prominin-1-containing membrane particles in the culture medium upon differentiation of Caco-2 cells. Appearance of prominin-1-containing.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
MTORC1 regulates basal GLUT4 protein expression independent of VWR exercise. mTORC1 regulates basal GLUT4 protein expression independent of VWR exercise.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Nrf2−/− mice had higher TGF-β1 transcription and FN expression.
LSD1, a histone demethylase, is required for the assembly of the Notch repressor complex. LSD1, a histone demethylase, is required for the assembly of.
MYC degradation screen identifies a compound that stabilizes MYC protein. MYC degradation screen identifies a compound that stabilizes MYC protein. (A)
Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.
Curcumin-generated ROS activates Chk1 and Chk2 kinases.
Accumulation of ubiquitinated MDM2 following PN treatment requires the PIKK ATM. A, Western blots of nuclear extract proteins from ZR-75-1 cells treated.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
GA blocks HIF activity and reduces HIF target expression.
A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.
VHL-, oxygen-, and proteasome-dependent regulation of AUF1 expression in RCC and 293T cells. VHL-, oxygen-, and proteasome-dependent regulation of AUF1.
PX-478 inhibits hypoxic HIF-1 protein expression and signaling activity in a dose-dependent manner. PX-478 inhibits hypoxic HIF-1 protein expression and.
VP16-E2 is a more potent transcriptional activator than Gal4-VP16.
Variation in dUTPase expression in cell lines.
Synergistic effect of CNP and doxorubicin (DOX) on thiol oxidation.
Induction of CDCP1 is regulated by Ras in NSCLC cells.
Lamellarin D induces cell death through a Fas-independent pathway.
Depletion of HDAC2 sensitizes cells to epirubicin-induced apoptosis.
Greater induction of apoptosis following EGFR TKI treatment correlates with higher basal BIM expression across a panel of EGFR-mutant lung cancers. Greater.
A, top, representative Western blot for Ku70 in MCF7 cell extracts following siRNA knockdown of Ku70, compared with siRNA control. A, top, representative.
Effect of G9a on the expression of GSH synthesis enzymes.
Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. A, MM.1S.
ONC201 activates an ISR, decreases cyclin D1 expression, and causes an accumulation of cells in G1 in TNBC cells sensitive to the compounds' antiproliferative.
Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.
GA reduces the growth of Caki-1 tumor xenografts.
HDACI treatment leads to down-regulation of AR and neuroendocrine transdifferentiation of LNCaP or LAPC4 cells. HDACI treatment leads to down-regulation.
Src expression in a panel of human TCC cell lines.
The AKT–mTOR pathway controls PD-L1 protein expression.
Radiation does not alter AKT and MTOR gene expression.
Cells lacking CDK6 kinase function are required to mutate p53.
Incorporation of the TSTA system into a single plasmid.
Pharmacodynamic evaluation of VT-464 and ABI in MR49F xenograft model.
A, P causes G2-M arrest with apoptosis in asynchronous population of PC-3 when exposed to 1.5 and 5 μmol/L P for various time points. A, P
A and B, comparison of time course of TFF1 mRNA induction under estrogen-withdrawn (denoted ph−/ES−) and estrogenic medium (denoted ph+/ES+) conditions.
Effects of EGCG on the anchorage-independent growth of EFT cells.
Platinum-based chemotherapy increased TXNIP expression, and overexpression of TXNIP enhanced the effectiveness of this therapy. Platinum-based chemotherapy.
A, expression of p53 downstream mediator p21.
Changes in signal transduction pathway induced by gefitinib.
NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.
EGFR signaling regulates transcription of PDGFRβ gene.
Osteoactivin expression is required for the invasive phenotype of in vivo selected bone metastatic 4T1 breast cancer cells. Osteoactivin expression is.
MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E. MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E.
AR inhibition decreases ER+/AR+ breast cancer growth.
Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and.
The effects of AZD1775 and olaparib on DNA damage response signaling.
AKT activation in HCC2429 is SRC- but not Notch-dependent.
P53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo.
A, left: LNCaP cells were cultured in media containing complete serum, treated for 24 hours with either ethanol control (0.01%), ABT888 (2.5 mmol/L), or.
ER stress mediates postslippage AMPK activation.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Expression of chemokine receptors in A-498 cell line.
Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105. Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
A, indicated model systems were cultured in media containing complete serum, harvested, and lysed; total protein was separated by SDS-PAGE, transferred.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
MYC is required for the hypoxic induction of SHMT2.
Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced.
Treatment with octyl-D-2-HG and octyl-L-2-HG reduces MIR148A expression. Treatment with octyl-D-2-HG and octyl-L-2-HG reduces MIR148A expression. A, Treatment.
Presentation transcript:

Gramicidin A (GA) decreases HIF protein expression in RCC cells. Gramicidin A (GA) decreases HIF protein expression in RCC cells. A, RCC cells were treated with vehicle or GA in normoxic (21% O2) or hypoxic (1% O2) conditions for 24 hours and protein expression was measured by immunoblot analysis. B, RCC cells were treated with vehicle or GA and relative transcript expression of HIF-1α (top) and HIF-2α (bottom) was measured by qRT-PCR. Graphs, mean ± SE of three independent experiments. *, P < 0.05. C, hypoxic SN12C cells were treated with vehicle or 0.5 μmol/L of the indicated ionophore for the indicated time points and protein expression was measured by immunoblot analysis. Justin M. David et al. Mol Cancer Ther 2014;13:788-799 ©2014 by American Association for Cancer Research